Study to Assess Clinical Characteristics and Outcome of Patients with Marginal Zone Lymphomas
NCT06806488
·
clinicaltrials.gov ↗
RECRUITING
Status
160
Enrollment
OTHER
Sponsor class
Conditions
Marginal Zone B Cell Lymphoma
Sponsor
IRCCS Azienda Ospedaliero-Universitaria di Bologna